Table 2.
Bone marrow examination in six COVID-19 patients.
| Cell types (%) | M1 | M2 | M3 | S1 | S2 | S3 | ||
|---|---|---|---|---|---|---|---|---|
|
Promyelocyte (RR: 0.97–2.17) |
1.50 | – | – | – | 1.50 | – | ||
|
Neutrophil-myelocyte (RR: 4.45–8.53) |
7.50 | 6.00 | 7.80 | 1.50 | 3.50 | – | ||
|
Neutrophil-metamyelocyte (RR: 5.93–9.87) |
11.50 | 7.00 | 12.50 | 4.50 | 10.50 | – | ||
|
Banded neutrophil (RR: 20.22–27.20) |
18.00 | 8.50 | 17.00 | 18.50 | 18.50 | 6.00 | ||
|
Segmented neutrophil (RR: 6.52–12.36) |
14.50 | 33.00 | 10.30 | 43.50 | 20.50 | 70.00 | ||
|
Eosinophil-myelocyte (RR: 0.15–0.61) |
0.50 | – | – | – | – | – | ||
|
Eosinophil-metamyelocyte (RR: 0.17–0.81) |
1.00 | – | 0.50 | – | – | – | ||
|
Banded eosinophil (RR: 0.64–1.86) |
0.50 | – | – | – | 0.50 | – | ||
|
Segmented eosinophil (RR: 0.25–1.47) |
– | 1.00 | 2.00 | 7.00 | 0.50 | 1.00 | ||
|
Prorubricyte (RR: 0.51–1.33) |
2.00 | 1.00 | 1.30 | – | 2.50 | – | ||
|
Rubricyte (RR: 5.50–9.32) |
12.50 | 5.50 | 4.50 | 0.50 | 9.50 | – | ||
|
Metarubricyte (RR: 8.39–13.11) |
19.00 | 16.50 | 33.50 | 1.50 | 13.00 | – | ||
|
Mature lymphocyte (RR: 15.74–29.82) |
9.00 | 17.50 | 9.50 | 15.00 | 14.50 | 18.00 | ||
|
Mature monocyte (RR: 0.00–3.00) |
1.50 | 3.50 | 0.80 | 8.00 | 3.00 | 5.00 | ||
|
Mature plasma cell (RR: 0.00–0.71) |
1.00 | 0.50 | 0.30 | – | 2.00 | – | ||
|
Total granulocyte (RR: 40.00–60.00) |
55.00 | 55.50 | 50.20 | 75.00 | 55.50 | 77.00 | ||
|
Total erythrocyte (RR: 20.00–25.00) |
33.50 | 23.00 | 39.20 | 2.00 | 25.00 | 0.00 | ||
| Erythrocyte/nucleated cell ratio | 0.50 | 0.30 | 0.64 | 0.02 | 0.33 | 0.00 | ||
RR reference range.